Japan Oncology Clinical Trials Market Analysis

Japan Oncology Clinical Trials Market Analysis


$ 3999

Japan's oncology clinical trials market is projected to grow from $0.79 Bn in 2022 to $1.25 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by a well-established healthcare system, advanced infrastructure, and a high prevalence of cancer. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Chugai Pharmaceutical Co., Ltd. & Ono Pharmaceutical Co., Ltd.

ID: IN10JPCT006 CATEGORY: Clinical Trials GEOGRAPHY: Japan AUTHOR: Vidhi Upadhyay

Buy Now

Japan Oncology Clinical Trials Market Executive Summary

Japan's oncology clinical trials market is projected to grow from $0.79 Bn in 2022 to $1.25 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. Japan is one of the world's major pharmaceutical markets, accounting for around 7% of worldwide sales. The anti-cancer medicine market is one such area of development in Japan, as it is elsewhere. The oncology market is expected to increase at a 5.2% CAGR through 2026. Cancer is one of Japan's top three major causes of death, and the government is progressively emphasizing patient-centered cancer research and treatment, most notably via the third iteration of the national Basic Plan to Promote Cancer Control. In Japan, there were 1,028,658 new cases of cancer as per the data by Globocan 2020.

Clinical trials are primarily concerned with the development of novel medications, treatments, and therapies for different stages and forms of cancer. Japan has been especially active in conducting clinical trials for lung cancer, the country's one of the largest causes of cancer-related mortality, as well as other prevalent malignancies such as breast, colorectal, and pancreatic cancer. The nation has also been at the forefront of developing novel cancer therapies such as immunotherapy and targeted therapy, as well as conducting clinical trials in these areas.

Japan is one of the world's top nations for oncology clinical trials. Because of its well-established healthcare system, modern infrastructure, and high cancer incidence, a nation is an appealing place for clinical research. Japan has also adopted a number of regulatory changes in recent years in order to expedite the clinical trial process and encourage more international investment in the pharmaceutical business.

japan oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

The country's developed healthcare system, high cancer incidence, legislative changes, robust research infrastructure, and innovative collaborations. Because of the high prevalence of cancer, especially among the elderly, Japan has a huge patient pool. With simplified clinical trial protocols and an established body to examine and approve pharmaceuticals and medical devices, the country's regulatory framework is also advantageous for clinical research. Moreover, the Japanese government supports and funds oncology clinical trials, attracting both local and foreign pharmaceutical firms to participate in the country's clinical research. Additionally, Japan's highly skilled experts and excellent technology make it an attractive venue for clinical studies.

Market Restraints

There are several constraints that may impede the expansion of oncology clinical trials in Japan. One barrier is the aging population, which may result in a smaller patient pool and make recruiting patients for clinical trials more challenging. Another barrier that smaller pharmaceutical businesses may face is the high expense of performing clinical trials in Japan. Moreover, linguistic and cultural barriers may make conducting clinical trials in Japan complicated for international organizations. Third, there is competition from other nations like as China and South Korea, who are both significantly investing in oncology clinical research and may entice investment away from Japan.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Bristol Myers Squibb Co.
  • Roche Holding AG
  • Chugai Pharmaceutical Co., Ltd. (JPN)
  • Daiichi Sankyo Company, Limited (JPN)
  • Eisai Co., Ltd. (JPN)
  • Kyowa Kirin Co., Ltd. (JPN)
  • Ono Pharmaceutical Co., Ltd. (JPN)
  • Shionogi & Co., Ltd. (JPN)

Notable Insights

  1. In November 2022, Daiichi Sankyo's breast cancer therapy has been approved by Japan's MHLW. The approval was based on the results of Enhertu's Phase III DESTINY-Breast03 study
  2. September 2022, Merck, also known as MSD, said that its anti-PD-1 medication KEYTRUDA gained four additional approvals from Japan's Ministry of Health, Labor, and Welfare (MHLW) Including in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)
  3. March 2022, CIRCULATE-Japan Colorectal Cancer Findings were updated. The CIRCULATE-Japan trial is a three-arm study of patients with stage II and III colon or rectal cancer

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Japan's Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up